BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26625899)

  • 21. Characteristics associated with mammography screening among both Hispanic and non-Hispanic white women.
    Borrayo EA; Hines L; Byers T; Risendal B; Slattery ML; Sweeney C; Baumgartner KB; Giuliano A
    J Womens Health (Larchmt); 2009 Oct; 18(10):1585-894. PubMed ID: 19754247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
    Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S
    Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
    Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
    JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing elderly women's mammography screening decisions: implications for counseling.
    Schonberg MA; McCarthy EP; York M; Davis RB; Marcantonio ER
    BMC Geriatr; 2007 Nov; 7():26. PubMed ID: 18021402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density.
    Chen J; Pee D; Ayyagari R; Graubard B; Schairer C; Byrne C; Benichou J; Gail MH
    J Natl Cancer Inst; 2006 Sep; 98(17):1215-26. PubMed ID: 16954474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer.
    Tice JA; Miglioretti DL; Li CS; Vachon CM; Gard CC; Kerlikowske K
    J Clin Oncol; 2015 Oct; 33(28):3137-43. PubMed ID: 26282663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women.
    Chay WY; Ong WS; Tan PH; Jie Leo NQ; Ho GH; Wong CS; Chia KS; Chow KY; Tan M; Ang P
    Breast Cancer Res; 2012 Jan; 14(1):R19. PubMed ID: 22289271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency and predictive value of a mammographic recommendation for short-interval follow-up.
    Yasmeen S; Romano PS; Pettinger M; Chlebowski RT; Robbins JA; Lane DS; Hendrix SL
    J Natl Cancer Inst; 2003 Mar; 95(6):429-36. PubMed ID: 12644536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of screening mammography among women with and without a first-degree relative with breast cancer.
    Kerlikowske K; Carney PA; Geller B; Mandelson MT; Taplin SH; Malvin K; Ernster V; Urban N; Cutter G; Rosenberg R; Ballard-Barbash R
    Ann Intern Med; 2000 Dec; 133(11):855-63. PubMed ID: 11103055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
    Quante AS; Whittemore AS; Shriver T; Strauch K; Terry MB
    Breast Cancer Res; 2012 Nov; 14(6):R144. PubMed ID: 23127309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the Gail et al. model for predicting individual breast cancer risk.
    Spiegelman D; Colditz GA; Hunter D; Hertzmark E
    J Natl Cancer Inst; 1994 Apr; 86(8):600-7. PubMed ID: 8145275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer.
    Phipps AI; Chlebowski RT; Prentice R; McTiernan A; Wactawski-Wende J; Kuller LH; Adams-Campbell LL; Lane D; Stefanick ML; Vitolins M; Kabat GC; Rohan TE; Li CI
    J Natl Cancer Inst; 2011 Mar; 103(6):470-7. PubMed ID: 21346227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors Associated with False Positive Results on Screening Mammography in a Population of Predominantly Hispanic Women.
    McGuinness JE; Ueng W; Trivedi MS; Yi HS; David R; Vanegas A; Vargas J; Sandoval R; Kukafka R; Crew KD
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):446-453. PubMed ID: 29382701
    [No Abstract]   [Full Text] [Related]  

  • 34. Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.
    Chlebowski RT; Anderson GL; Aragaki AK; Prentice R
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26546117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density.
    Hou N; Hong S; Wang W; Olopade OI; Dignam JJ; Huo D
    J Natl Cancer Inst; 2013 Sep; 105(18):1365-72. PubMed ID: 24003037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of Breast Cancer Risk-Assessment Models in a Large Mammography Cohort.
    McCarthy AM; Guan Z; Welch M; Griffin ME; Sippo DA; Deng Z; Coopey SB; Acar A; Semine A; Parmigiani G; Braun D; Hughes KS
    J Natl Cancer Inst; 2020 May; 112(5):489-497. PubMed ID: 31556450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.
    Anderson GL; Chlebowski RT; Aragaki AK; Kuller LH; Manson JE; Gass M; Bluhm E; Connelly S; Hubbell FA; Lane D; Martin L; Ockene J; Rohan T; Schenken R; Wactawski-Wende J
    Lancet Oncol; 2012 May; 13(5):476-86. PubMed ID: 22401913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.
    McCarthy AM; Keller B; Kontos D; Boghossian L; McGuire E; Bristol M; Chen J; Domchek S; Armstrong K
    Breast Cancer Res; 2015 Jan; 17(1):1. PubMed ID: 25567532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptor positive tumors: do reproductive factors explain differences in incidence between black and white women?
    Warner ET; Tamimi RM; Boggs DA; Rosner B; Rosenberg L; Colditz GA; Palmer JR
    Cancer Causes Control; 2013 Apr; 24(4):731-9. PubMed ID: 23380944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective approach to breast cancer risk prediction in African American women: the black women's health study model.
    Boggs DA; Rosenberg L; Adams-Campbell LL; Palmer JR
    J Clin Oncol; 2015 Mar; 33(9):1038-44. PubMed ID: 25624428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.